Not finding it? Sign in to also search OpenAlex live.
-
Improvement in Patient-reported Disease Severity, Cognitive Functioning, and Fatigue in Patients With Narcolepsy Type One Treated With Alixorexton, an Orexin Two Receptor Agonist, in the Vibrance-1 Phase Two Study (P6-14.002)
Yves A Dauvilliers, Ronald Grunstein, Emmanuel Mignot, Gerrit Lammers, David Plante, Erik Buntinx, +7 more
0citations -
Efficacy and Safety of TAK-861, an Oral Orexin Receptor 2 Agonist, in Individuals with Narcolepsy Type 1: Results from a Phase 2 Trial and Long-Term Extension Study Interim Analysis (P12-4.002)
Yves A Dauvilliers, Emmanuel Mignot, Giuseppe Plazzi, Gert Jan Lammers, Harisha Kadali, Ellie Stukalin, +6 more
1citations
11 results